689 related articles for article (PubMed ID: 27864418)
1. AMPK-ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem Cells.
Jang JE; Eom JI; Jeung HK; Cheong JW; Lee JY; Kim JS; Min YH
Clin Cancer Res; 2017 Jun; 23(11):2781-2794. PubMed ID: 27864418
[No Abstract] [Full Text] [Related]
2. Targeting AMPK-ULK1-mediated autophagy for combating BET inhibitor resistance in acute myeloid leukemia stem cells.
Jang JE; Eom JI; Jeung HK; Cheong JW; Lee JY; Kim JS; Min YH
Autophagy; 2017 Apr; 13(4):761-762. PubMed ID: 28118076
[TBL] [Abstract][Full Text] [Related]
3. BET inhibitor JQ1 suppresses cell proliferation via inducing autophagy and activating LKB1/AMPK in bladder cancer cells.
Li F; Yang C; Zhang HB; Ma J; Jia J; Tang X; Zeng J; Chong T; Wang X; He D; Guo P
Cancer Med; 2019 Aug; 8(10):4792-4805. PubMed ID: 31250978
[TBL] [Abstract][Full Text] [Related]
4. Targeted inhibition of ULK1 enhances daunorubicin sensitivity in acute myeloid leukemia.
Qiu L; Zhou G; Cao S
Life Sci; 2020 Feb; 243():117234. PubMed ID: 31887299
[TBL] [Abstract][Full Text] [Related]
5. Low-dose triptolide enhances antitumor effect of JQ1 on acute myeloid leukemia through inhibiting RNA polymerase II in vitro and in vivo.
Shi Y; Zhao H; Ye J; Li Z; Deng M; Zha J; Zhou Y; Zeng H; Lin Y; Pu X; Guo C; Song H; Qiu Y; Xu B
Mol Carcinog; 2020 Sep; 59(9):1076-1087. PubMed ID: 32691884
[TBL] [Abstract][Full Text] [Related]
6. ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia.
Hwang DY; Eom JI; Jang JE; Jeung HK; Chung H; Kim JS; Cheong JW; Min YH
J Exp Clin Cancer Res; 2020 May; 39(1):85. PubMed ID: 32393312
[TBL] [Abstract][Full Text] [Related]
7. Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer.
Luan W; Pang Y; Li R; Wei X; Jiao X; Shi J; Yu J; Mao H; Liu P
Onco Targets Ther; 2019; 12():8063-8074. PubMed ID: 31632060
[TBL] [Abstract][Full Text] [Related]
8. Hsp90 inhibitor, BIIB021, induces apoptosis and autophagy by regulating mTOR-Ulk1 pathway in imatinib-sensitive and -resistant chronic myeloid leukemia cells.
He W; Ye X; Huang X; Lel W; You L; Wang L; Chen X; Qian W
Int J Oncol; 2016 Apr; 48(4):1710-20. PubMed ID: 26892093
[TBL] [Abstract][Full Text] [Related]
9. Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.
Herrmann H; Blatt K; Shi J; Gleixner KV; Cerny-Reiterer S; Müllauer L; Vakoc CR; Sperr WR; Horny HP; Bradner JE; Zuber J; Valent P
Oncotarget; 2012 Dec; 3(12):1588-99. PubMed ID: 23249862
[TBL] [Abstract][Full Text] [Related]
10. GCA links TRAF6-ULK1-dependent autophagy activation in resistant chronic myeloid leukemia.
Han SH; Korm S; Han YG; Choi SY; Kim SH; Chung HJ; Park K; Kim JY; Myung K; Lee JY; Kim H; Kim DW
Autophagy; 2019 Dec; 15(12):2076-2090. PubMed ID: 30929559
[TBL] [Abstract][Full Text] [Related]
11. Silencing of NRAGE induces autophagy via AMPK/Ulk1/Atg13 signaling pathway in NSCLC cells.
Zhou Y; Huang N; Wu J; Zhen N; Li N; Li Y; Li YX
Tumour Biol; 2017 Jun; 39(6):1010428317709676. PubMed ID: 28639909
[TBL] [Abstract][Full Text] [Related]
12. Lack of mitochondrial DNA impairs chemical hypoxia-induced autophagy in liver tumor cells through ROS-AMPK-ULK1 signaling dysregulation independently of HIF-1α.
Marin JJG; Lozano E; Perez MJ
Free Radic Biol Med; 2016 Dec; 101():71-84. PubMed ID: 27687210
[TBL] [Abstract][Full Text] [Related]
13. BET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITD.
Fiskus W; Sharma S; Qi J; Shah B; Devaraj SG; Leveque C; Portier BP; Iyer S; Bradner JE; Bhalla KN
Mol Cancer Ther; 2014 Oct; 13(10):2315-27. PubMed ID: 25053825
[TBL] [Abstract][Full Text] [Related]
14. ULK1 plays a critical role in AMPK-mediated myocardial autophagy and contractile dysfunction following acute alcohol challenge.
Kandadi MR; Hu N; Ren J
Curr Pharm Des; 2013; 19(27):4874-87. PubMed ID: 23448468
[TBL] [Abstract][Full Text] [Related]
15. PERK/NRF2 and autophagy form a resistance mechanism against G9a inhibition in leukemia stem cells.
Jang JE; Eom JI; Jeung HK; Chung H; Kim YR; Kim JS; Cheong JW; Min YH
J Exp Clin Cancer Res; 2020 Apr; 39(1):66. PubMed ID: 32293500
[TBL] [Abstract][Full Text] [Related]
16. GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1.
Kumar K; Raza SS; Knab LM; Chow CR; Kwok B; Bentrem DJ; Popovic R; Ebine K; Licht JD; Munshi HG
Sci Rep; 2015 Mar; 5():9489. PubMed ID: 25807524
[TBL] [Abstract][Full Text] [Related]
17. BET Protein Inhibition Prolongs Cardiac Transplant Survival via Enhanced Myocardial Autophagy.
Chen J; Miao X; Liu C; Liu B; Wu X; Kong D; Sun Q; Gong W
Transplantation; 2020 Nov; 104(11):2317-2326. PubMed ID: 32433238
[TBL] [Abstract][Full Text] [Related]
18. Blockage of AMPK-ULK1 pathway mediated autophagy promotes cell apoptosis to increase doxorubicin sensitivity in breast cancer (BC) cells: an in vitro study.
Yu L; Shi Q; Jin Y; Liu Z; Li J; Sun W
BMC Cancer; 2021 Feb; 21(1):195. PubMed ID: 33632157
[TBL] [Abstract][Full Text] [Related]
19. Aconitine induces autophagy via activating oxidative DNA damage-mediated AMPK/ULK1 signaling pathway in H9c2 cells.
Wang W; Jiang J; Huang Y; Peng F; Hu T; Wu J; Pan X; Rao C
J Ethnopharmacol; 2022 Jan; 282():114631. PubMed ID: 34520828
[TBL] [Abstract][Full Text] [Related]
20. SBI0206965, a novel inhibitor of Ulk1, suppresses non-small cell lung cancer cell growth by modulating both autophagy and apoptosis pathways.
Tang F; Hu P; Yang Z; Xue C; Gong J; Sun S; Shi L; Zhang S; Li Z; Yang C; Zhang J; Xie C
Oncol Rep; 2017 Jun; 37(6):3449-3458. PubMed ID: 28498429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
